The Oncology Institute Joins Lantern’s Cancer Care Network
The Oncology Institute, Inc. (NASDAQ: TOI), recognized as one of the largest value-based oncology groups in the nation, has recently joined forces with Lantern's prominent specialty care platform. Through this collaboration, members of Lantern will now have access to exceptional cancer care at any of The Oncology Institute's advanced community clinics, which are strategically positioned across several states.
Commitment to Advanced Cancer Care
Dr. Dan Virnich, the Chief Executive Officer of The Oncology Institute, emphasized the organization's dedication to making cutting-edge cancer treatments accessible to every patient. "At TOI, we believe that every cancer patient deserves access to the most advanced care in their community," he stated. This partnership with Lantern is an exciting opportunity to create a new cancer care option for employers, focusing on achieving optimal health outcomes while ensuring patient satisfaction. Additionally, this initiative is set to alleviate the financial burdens that often accompany cancer treatment, all while aligning with TOI's mission and the community's needs.
Supporting Employees During Critical Times
Nicki MacManus, the Senior Vice President and General Manager of Cancer Care at Lantern, shared insights into the company’s mission and vision. She highlighted, "A cancer diagnosis can be one of the most overwhelming moments in healthcare, and our goal is to help employers connect their employees with the best cancer care, when they need it most." Lantern's foundational principle has been to provide access to top-performing specialty care providers, and the partnership with The Oncology Institute embodies this commitment to excellence and accessibility.
Lantern's Network of Excellence
Lantern stands out as a specialized care platform designed to connect individuals with the best healthcare solutions precisely when they need them the most. By establishing a Network of Excellence that includes the nation's leading providers across various specialties like cancer care, surgery, and infusion therapies, Lantern delivers not only superior healthcare services but also significant cost savings to employers and their workforce. The platform ensures that every member is paired with a dedicated care team, consisting of Care Advocates and nurses, to support them throughout their entire healthcare journey. This holistic approach is critical, ensuring that patients can return to good health, reunite with their families, and re-enter the workforce with minimal disruption.
Focus on Patient-Centric Care
The Oncology Institute, founded in 2007, is on a mission to revolutionize oncology through the provision of specialized, value-based cancer care in community settings. TOI has successfully delivered state-of-the-art, evidence-based cancer treatment to over 1.8 million patients through various services, including clinical trials and transfusions. The organization boasts a robust team of over 120 employed clinicians and more than 700 dedicated staff members across its 70+ clinic locations. Their commitment to changing oncology for the better is evident in their ongoing efforts to elevate care standards.
Your Pathway to Cancer Care
With Lantern's extensive reach and The Oncology Institute's specialized care network, patients can now experience a simpler and more effective pathway to cancer treatment. The streamlined access provides a promising outlook not only for those battling cancer but also for employers striving to support their workforce during difficult times.
Contact Information for Investors
For investor inquiries, Solebury Strategic Communications can be contacted via email at investors@theoncologyinstitute.com. For additional information about The Oncology Institute and its services, you can visit their website at www.theoncologyinstitute.com.
Frequently Asked Questions
What is the partnership between The Oncology Institute and Lantern?
The partnership allows Lantern members access to advanced cancer care provided by The Oncology Institute at community clinics in multiple states.
How does this collaboration benefit cancer patients?
This collaboration expands access to high-quality cancer treatment, enhances patient satisfaction, and reduces costs associated with care.
Who is Dr. Dan Virnich?
Dr. Dan Virnich is the Chief Executive Officer of The Oncology Institute, leading efforts to make advanced cancer care accessible.
What is Lantern's goal regarding cancer care?
Lantern aims to connect employees with the best cancer care providers, ensuring they receive essential treatment during trying times.
How many patients does The Oncology Institute serve?
The Oncology Institute provides services to over 1.8 million patients, focusing on specialized, evidence-based cancer care.
